Over the past 16 months, Chinese-domiciled biopharmaceutical companies have emerged as significant players in the global drug development landscape, participating…
Read More

Over the past 16 months, Chinese-domiciled biopharmaceutical companies have emerged as significant players in the global drug development landscape, participating…
Read More
A landmark randomized clinical trial published in JACC, the flagship journal of the American College of Cardiology, has revealed that…
Read More
A significant body of new evidence from Rutgers Health suggests that the psychological tendency to turn stress inward—a phenomenon known…
Read More
Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as significant players in the global pharmaceutical landscape, securing approximately…
Read More
A groundbreaking study published in JACC, the flagship journal of the American College of Cardiology, has revealed that Baduanjin, a…
Read More
The majority of these high-value collaborations, roughly half, involved firms of U.S. origin, predominantly structured as mergers and acquisitions (M&A).…
Read More
A groundbreaking longitudinal study conducted by the Rutgers Institute for Health, Health Care Policy and Aging Research has identified a…
Read More
A groundbreaking study published in the Journal of the American College of Cardiology (JACC), the flagship publication of the American…
Read More
Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
New research from the Rutgers Institute for Health, Health Care Policy and Aging Research has identified a significant correlation between…
Read More